Furthermore, DNA methylation changes in selected ZNF genes (ZNF14, ZNF 160, and ZNF420) are detectable in both tumor and saliva of HNSCC patients with high specificity and represent promising biomarkers for the development of non-invasive assays for the detection and surveillance of HNSCC. This evidence concerns the gene ZNF14 and head and neck squamous cell carcinoma.